The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Genetic analysis of von Hippel-Lindau disease
Open accessAbstract
Mutations in the von Hippel-Lindau (VHL) gene are responsible for VHL disease, congenital polycythemia, and are found in many sporadic tumor types as well. Reports of VHL mutations are dispersed throughout original articles and databases that have not been recently updated. We compiled a comprehensive mutation table of 1,548 germline and somatic VHL mutations, derived from this protein of only 213 amino acids. We describe detailed phenotype and gene mutation information for 945 VHL families, including 30 previously unpublished kindreds from The Netherlands (six novel mutations). These data represent the most extensive catalog of germline VHL mutations to date. We also review VHL disease, known and theorized pathogenesis of common VHL manifestations, and genotype-phenotype correlations. Analysis of all VHL families, excluding germline mutations resulting in congenital polycythemias, describes the spectrum of mutation types: 52% missense, 13% frameshift, 11% nonsense, 6% in-frame deletions/insertions, 11% large/complete deletions, and 7% splice mutations. This easy-to-use compilation of VHL mutations is intended to facilitate research and function as a necessary adjunct for physicians when providing patient information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–208 of 208
Cho, H.-J., Ki, C., & Kim, J. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.1.77 · Cited by 28
Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene
Dj, G. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.147 · Cited by 21
Genetic signature for human risk assessment: Lessons from trichloroethylene
Shiao, Y. (2008) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20432 · Cited by 18
Novel somatic mutations in the VHL gene in Swedish archived sporadic renal cell carcinomas
Yang, K., Lindblad, P., Egevad, L., & Hemminki, K. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00031-2 · Cited by 17
Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma
Hughson, M. D., He, Z., Liu, S., Coleman, J. P., & Shingleton, W. B. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00856-7 · Cited by 12
Atuk, N. O. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.117 · Cited by 10
The Challenge of Kidney Lesions in von Hippel-Lindau Disease
Neumann, H. P. H., Riegler, P., Huber, W., et al. (2001) · KARGER eBooks · doi:10.1159/000060187 · Cited by 4
Stolle, C. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-87366-4_9 · Cited by 4
Cited by
VHL, the story of a tumour suppressor gene
Gossage, L., Eisen, T., & Maher, E. R. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3844 · Cited by 774
von Hippel–Lindau disease: A clinical and scientific review
Maher, E. R., Neumann, H. P., & Richard, S. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.175 · Cited by 729
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr324 · Cited by 309
Rednam, S. P., Erez, A., Druker, H., Janeway, K. A., Kamihara, J., Kohlmann, W. K., Nathanson, K. L., States, L. J., Tomlinson, G. E., Villani, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0547 · Cited by 280
The SOCS box—Adapting proteins for ubiquitination and proteasomal degradation
Linossi, E. M., & Nicholson, S. E. (2012) · IUBMB Life · doi:10.1002/iub.1011 · Cited by 122
Metadata
- Authors
- Nordstrom-O'Brien, M., van der Luijt, R. B., van Rooijen, E., van den Ouweland, A. M., Majoor-Krakauer, D. F., Lolkema, M. P., van Brussel, A., Voest, E. E., & Giles, R. H.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2010
- Volume
- 31
- Issue
- 5
- Pages
- n/a-n/a
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2061329487
- Cited by
- 311
- References
- 208
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.